Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Osteosarcoma 1Lung Metastases 1Humoral Hypercalcemia Of Malignancy 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Zoledronic Acid 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Humoral Hypercalcemia Of Malignancy × Zoledronic Acid × Clear all
NCT00326820 2013-03-13

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Wales Cancer Trials Unit

Phase 3 Unknown
1,404 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡